Adjuvant chemotherapy for pulmonary sarcomatoid carcinoma: A retrospective analysis of the National Cancer Database

医学 比例危险模型 癌症 肺癌 肿瘤科 阶段(地层学) 内科学 回顾性队列研究 辅助治疗 队列 癌症登记处 化疗 生存分析 外科 古生物学 生物
作者
Hussein Abdallah,Deirdre Martinez‐Meehan,Waseem Lutfi,Rajeev Dhupar,Tyler R. Grenda,Matthew J. Schuchert,Neil A. Christie,James D. Luketich,Olugbenga T. Okusanya
出处
期刊:The Journal of Thoracic and Cardiovascular Surgery [Elsevier BV]
卷期号:163 (5): 1669-1681.e3 被引量:25
标识
DOI:10.1016/j.jtcvs.2021.01.081
摘要

Abstract Objectives Pulmonary sarcomatoid carcinoma (PSC) is a rarely occurring variant of non-small cell lung cancer with sarcoma-like features. Compared with traditional non-small cell lung cancer, PSC patients typically present later and have poorer prognoses, irrespective of stage. The standard of care is resection, but guidelines for the use of adjuvant chemotherapy have not been established. To advance the development of evidence-based management algorithms for PSC after resection, a statistical analysis on a nationwide representative sample of patients was performed. Methods A retrospective cohort study was performed by querying the National Cancer Database for patients with a diagnosis of PSC between 2004 and 2015. Patients who received complete anatomical resection with or without adjuvant chemotherapy were included. Multivariable regression was used to detect factors associated with the receipt of adjuvant chemotherapy. Multivariable Cox regression of overall survival and Kaplan-Meier survival analysis on propensity-matched groups was conducted to study the association between adjuvant chemotherapy and prognosis. Results We included 1497 patients with PSC in the final analysis. Factors associated with receiving adjuvant chemotherapy were age, histology, and receipt of adjuvant radiation. The results of multivariable Cox analysis and Kaplan-Meier analysis on propensity matched groups yielded similar trends: adjuvant chemotherapy was associated with improved 5-year overall survival for stage II and III disease, but not for stage I disease. Conclusions Multiple factors are associated with receipt of adjuvant chemotherapy for PSC, and this treatment appears to be associated with improved survival in stage II and stage III, but not stage I patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
天天快乐的应助被科研通管家采纳,获得10
1秒前
天天向上的应助被科研通管家采纳,获得10
2秒前
orixero的应助被科研通管家采纳,获得10
2秒前
不爱喝酒的应助被科研通管家采纳,获得10
2秒前
天天快乐的应助被科研通管家采纳,获得10
2秒前
gczl完成签到,获得积分10
2秒前
科目三的应助被科研通管家采纳,获得10
2秒前
小水滴发布了新的文献求助10
2秒前
李爱国的应助被科研通管家采纳,获得10
2秒前
AC赵先生完成签到,获得积分10
2秒前
星辰大海的应助被科研通管家采纳,获得10
2秒前
搜集达人的应助被科研通管家采纳,获得10
2秒前
无极微光的应助被科研通管家采纳,获得20
3秒前
脑洞疼的应助被科研通管家采纳,获得10
3秒前
qianhong完成签到,获得积分10
3秒前
3秒前
科研通AI65的应助被科研通管家采纳,获得10
3秒前
Lucas的应助被科研通管家采纳,获得10
3秒前
充电宝的应助被科研通管家采纳,获得10
3秒前
小二郎的应助被科研通管家采纳,获得10
3秒前
syvshc的应助被科研通管家采纳,获得10
3秒前
4秒前
Jun的应助被科研通管家采纳,获得10
4秒前
所所的应助被科研通管家采纳,获得10
4秒前
CodeCraft的应助被科研通管家采纳,获得10
4秒前
wyfuuu完成签到,获得积分10
4秒前
4秒前
SciGPT的应助被科研通管家采纳,获得10
4秒前
科目三的应助被科研通管家采纳,获得10
4秒前
JamesPei的应助被科研通管家采纳,获得10
4秒前
Lucas的应助被科研通管家采纳,获得10
5秒前
鸟窝的应助被科研通管家采纳,获得10
5秒前
ding的应助被科研通管家采纳,获得10
5秒前
阿申爱乐的应助被科研通管家采纳,获得30
5秒前
5秒前
顾矜的应助被科研通管家采纳,获得10
5秒前
5秒前
华仔的应助被科研通管家采纳,获得10
5秒前
5秒前
5秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186480
求助须知:如何正确求助?哪些是违规求助? 9574861
关于积分的说明 21838499
捐赠科研通 7784154
什么是DOI,文献DOI怎么找? 3434775
关于科研通互助平台的介绍 2559164
邀请新用户注册赠送积分活动 2481565